Archive for May, 2010

Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus

HORSHAM, Pa., June 1 /PRNewswire/ -- Centocor Ortho Biotech Inc. today announced that it has acquired RespiVert Ltd., a privately held drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases.  The company's lead compounds, RV-568...
READ THE FULL ARTICLE >>

Gundersen Lutheran Health System One of Few Heart Centers in the Nation Performing Minimally Invasive Multiple Bypass Surgery

LA CROSSE, Wis., June 1 /PRNewswire/ -- Surgeons at Gundersen Lutheran Heart Institute in La Crosse, Wis., are using an innovative technique, called minimally invasive coronary surgery (MICS), to perform multiple heart bypasses through a small incision. That means surgeons do not have to "crack...
READ THE FULL ARTICLE >>

MediSapiens Gets $ 1 Million for World’s First Personalized Cancer Medicine Software

HELSINKI, June 1, 2010 /PRNewswire/ -- MediSapiens, world's first software company for personalized cancer medicine in oncology clinics and drug development, completed $ 1 million (EUR 0.8 million) seed round investment from Veraventure, ETFIII advised by Eqvitec Partners, VTT Ventures and...
READ THE FULL ARTICLE >>

Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting

SEATTLE and SAN FRANCISCO, May 31 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced the presentation of safety data from the integrated analysis of four randomized PROVENGE® (sipuleucel-T) clinical trials of an autologous cellular immunotherapy in prostate cancer at...
READ THE FULL ARTICLE >>

Families Should Create a Hurricane Survival Plan, PADF Says

WASHINGTON, May 31 /PRNewswire/ -- On the eve of what is predicted to be one of the worst Atlantic hurricane seasons in years, the Pan American Development Foundation is urging residents in Central America and the Caribbean to put together emergency plans. (Logo:...
READ THE FULL ARTICLE >>

MDS Nordion Announces Changes to the Board

New Director Appointed and Two Directors Retire OTTAWA, May 31 /PRNewswire-FirstCall/ - MDS Nordion, a leader in providing products and services for the global health sciences market, today announced that Dr. Oye Olukotun, Chief Executive Officer of CardioVax Inc, has been appointed to its Board...
READ THE FULL ARTICLE >>

Elbit Imaging Ltd. Announces First Quarter Results for 2010

TEL AVIV, Israel, May 31, 2010 /PRNewswire-FirstCall/ -- Elbit Imaging Ltd. ("EI") (TASE, NASDAQ: EMITF) announced today its results for the first quarter of 2010. Loss for the first quarter of 2010 attributable to the equity holders of the company amounted to NIS 136 million (loss...
READ THE FULL ARTICLE >>

FAIR-HF Subanalysis Shows That Ferinject(R) Improves Kidney Function in Iron-Deficient Patients With Chronic Heart Failure

ZURICH and BERLIN, May 31, 2010 /PRNewswire/ -- Results of a subanalysis from the FAIR-HF (Ferinject(R) Assessment in patients with IRon deficiency and Chronic Heart Failure) study demonstrate that correcting iron deficiency with Ferinject(R) (ferric carboxymaltose) can improve renal function...
READ THE FULL ARTICLE >>

Health Robotics South East Asia Wins two key Cancer Therapy Outsourcing Projects in Malaysia and Thailand

BOZEN, Sud-Tirol, Italy, May 31, 2010 /PRNewswire/ -- Health Robotics today announced that its joint venture Health Robotics South East Asia Ltd. scored two strategic wins by reaching agreements on two separate government-sponsored projects to deliver CytoCare-made accurate and sterile oncology...
READ THE FULL ARTICLE >>

Phase 2 Clinical Trial Data Show Significant Improvements in Outcomes and Symptoms in Advanced Heart Failure Patients Treated with Celladon’s Genetically Targeted Enzyme Replacement Therapy MYDICAR®

BERLIN, May 30 /PRNewswire/ -- Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and...
READ THE FULL ARTICLE >>
« Older Entries
Get Adobe Flash playerPlugin by wpburn.com wordpress themes